The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. RxSight Inc shares valued at $143,078 were sold by Goldshleger Ilya on Nov 29 ’24. At $46.08 per share, Goldshleger Ilya sold 3,105 shares. The insider’s holdings dropped to 42,246 shares worth approximately $1.45 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, ILYA GOLDSHLEGER purchased 3,105 shares, netting a total of over 143,078 in proceeds.
Before that, Maniar Shweta had sold 3,782 shares from its account. In a trade valued at $173,518, the Director traded RxSight Inc shares for $45.88 each. Upon closing the transaction, the insider’s holdings decreased to 3,782 shares, worth approximately $0.37 million.
As published in a research note from Stifel on December 20, 2024, RxSight Inc [RXST] has been rated down from a Buy to a Hold and the price target has been revised to $40 from $65. Analysts at Wells Fargo downgraded the stock from ‘”an Overweight”‘ to ‘”an Equal weight”‘ outlook in a report released in mid December. As of December 06, 2024, UBS has initiated its “Buy” rating for RXST. Earlier on October 29, 2024, Jefferies initiated its rating. Their recommendation was “a Buy” for RXST stock.
Analyzing RXST Stock Performance
During the last five days, there has been a drop of approximately -0.61%. Over the course of the year, RxSight Inc shares have dropped approximately -14.73%. Shares of the company reached a 52-week high of $66.54 on 05/07/24 and a 52-week low of $33.03 on 12/30/24. A 50-day SMA is recorded $43.94, while a 200-day SMA reached $51.05. Nevertheless, trading volume fell to 0.7 million shares from 0.42 million shares the previous day.
Support And Resistance Levels for RxSight Inc (RXST)
According to the 24-hour chart, there is a support level at 33.72, which, if violated, would cause prices to drop to 33.06. In the upper region, resistance lies at 34.84. The next price resistance is at 35.30. RSI (Relative Strength Index) is 33.14 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.78, which suggests the price will decrease in the coming days. Percent R is at 78.71%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
